MARKET

SPHS

SPHS

Sophiris Bio
OTCMKTS

Real-time Quotes | Nasdaq Last Sale

0.2400
-0.0300
-11.11%
Closed 15:59 04/01 EDT
OPEN
0.2500
PREV CLOSE
0.2700
HIGH
0.2999
LOW
0.2400
VOLUME
163.88K
TURNOVER
41.66K
52 WEEK HIGH
1.170
52 WEEK LOW
0.1000
MARKET CAP
8.27M
P/E (TTM)
66.67
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SPHS stock price target is 3.250 with a high estimate of 3.750 and a low estimate of 2.750.

EPS

SPHS News

More
  • 90 Biggest Movers From Yesterday
  • Benzinga · 03/12 10:10
  • Mid-Afternoon Market Update: Dow Plunges Over 1300 Points As WHO Declares COVID-19 A Pandemic
  • Benzinga · 03/11 18:34
  • Mid-Day Market Update: Crude Oil Down 2.5%; Avid Bioservices Shares Fall After Q3 Results
  • Benzinga · 03/11 16:28
  • 78 Stocks Moving In Wednesday's Mid-Day Session
  • Benzinga · 03/11 16:12

Industry

Biotechnology & Medical Research
-4.52%
Pharmaceuticals & Medical Research
-2.91%

Hot Stocks

Symbol
Price
%Change

About SPHS

Sophiris Bio Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing products for the treatment of urological diseases. The Company is developing topsalysin (PRX302) as a treatment for the lower urinary tract symptoms of benign prostatic hyperplasia (BPH) commonly referred to as an enlarged prostate and as a treatment for localized low to intermediate risk prostate cancer. Topsalysin, a genetically modified recombinant protein, is delivered through ultrasound-guided injection directly into the prostate. This membrane-disrupting protein is selectively activated by enzymatically active prostate specific antigen (PSA), which is only present in the prostate, leading to localized cell death and tissue disruption without damage to neighboring tissue and nerves. This method of administration limits the circulation of the drug in the body. The Company has completed Phase III clinical trials of topsalysin.
More

Webull offers kinds of Sophiris Bio Inc stock information, including OTCMKTS:SPHS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPHS stock news, and many more online research tools to help you make informed decisions.